Elevating the future standards of
regenerative medicine

We at Kintaro Cells Power Corporation are working towards the future of regenerative medicine. Our product KINTARO Cells® are Human Allogeneic Bone Marrow Mesenchymal Stem Cells that are cultured using the most advanced biotechnologies. As a research and development company, it is our mission to elevate the standards of the regenerative medicine.

  • Company
  • Business
  • Product
  • News
  • Recent news

    • 2018/10/30
      BioJapan 2018
      On October 10-12th, KINTARO Cells Power exhibited in BioJapan & Regenerative Medicine Japan 2018 in Yokohama. There, our team provided information about our company and product to Japan’s leading ...
    • 2018/9/26
      Corporate Meeting at the Kintaro Branch Office in China
      September 26, at the KINTARO Cells Power branch in China, a corporate meeting was held. Our Executive Director’s Yoji Kishi and Tsuyoshi Fujimoto attended a discussion with hospital directors an...
    • 2018/9/20
      BioJapan & Regenerative Medicine Japan 2018
      In October, we will be attending BioJapan Expo 2018 BioJapan & Regenerative Medicine Japan, Asia’s premier partnering event for the global biotechnology industry. We are looking forward to s...
    *Note on trademark registration「金太郎細胞®」or “KINTARO Cells®